Slow Capital Inc. Increases Stock Position in The Clorox Company (NYSE:CLX)

Slow Capital Inc. lifted its holdings in The Clorox Company (NYSE:CLX) by 0.8% during the fourth quarter, Holdings Channel reports. The institutional investor owned 18,462 shares of the company’s stock after acquiring an additional 142 shares during the quarter. Slow Capital Inc.’s holdings in Clorox were worth $2,998,000 as of its most recent SEC filing.

Several other institutional investors also recently modified their holdings of CLX. Catalyst Capital Advisors LLC purchased a new stake in Clorox in the third quarter worth about $54,000. Los Angeles Capital Management LLC grew its stake in shares of Clorox by 5.6% in the 3rd quarter. Los Angeles Capital Management LLC now owns 191,919 shares of the company’s stock worth $31,266,000 after buying an additional 10,149 shares during the last quarter. Advisors Asset Management Inc. increased its position in Clorox by 43.4% during the 3rd quarter. Advisors Asset Management Inc. now owns 29,865 shares of the company’s stock valued at $4,865,000 after buying an additional 9,037 shares in the last quarter. Natixis Advisors LLC raised its stake in Clorox by 8.3% during the third quarter. Natixis Advisors LLC now owns 63,476 shares of the company’s stock valued at $10,341,000 after buying an additional 4,839 shares during the last quarter. Finally, Charles Schwab Investment Management Inc. boosted its holdings in Clorox by 1.8% in the third quarter. Charles Schwab Investment Management Inc. now owns 723,906 shares of the company’s stock worth $117,932,000 after acquiring an additional 13,038 shares in the last quarter. 78.53% of the stock is currently owned by institutional investors.

Clorox Price Performance

NYSE CLX opened at $162.35 on Tuesday. The company has a 50-day moving average price of $163.66 and a 200-day moving average price of $157.66. The Clorox Company has a 52 week low of $127.60 and a 52 week high of $171.37. The company has a quick ratio of 0.62, a current ratio of 1.00 and a debt-to-equity ratio of 11.08. The firm has a market capitalization of $20.10 billion, a P/E ratio of 56.57, a PEG ratio of 2.92 and a beta of 0.42.

Clorox (NYSE:CLX) last announced its earnings results on Wednesday, October 30th. The company reported $1.86 EPS for the quarter, beating analysts’ consensus estimates of $1.36 by $0.50. The business had revenue of $1.76 billion during the quarter, compared to analysts’ expectations of $1.64 billion. Clorox had a net margin of 4.78% and a return on equity of 316.08%. The firm’s revenue was up 27.0% on a year-over-year basis. During the same period in the prior year, the company earned $0.49 earnings per share. Equities research analysts anticipate that The Clorox Company will post 6.87 earnings per share for the current year.

Clorox Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, February 14th. Investors of record on Wednesday, January 29th will be given a dividend of $1.22 per share. The ex-dividend date is Wednesday, January 29th. This represents a $4.88 annualized dividend and a yield of 3.01%. Clorox’s dividend payout ratio (DPR) is presently 170.04%.

Analyst Upgrades and Downgrades

CLX has been the subject of several recent analyst reports. Barclays lowered their price target on Clorox from $139.00 to $130.00 and set an “underweight” rating for the company in a research report on Friday, January 17th. Jefferies Financial Group upgraded shares of Clorox from a “hold” rating to a “buy” rating and upped their target price for the stock from $174.00 to $187.00 in a research note on Tuesday, October 1st. Evercore ISI cut their price target on shares of Clorox from $140.00 to $139.00 and set an “underperform” rating on the stock in a report on Monday, October 14th. TD Cowen upgraded shares of Clorox from a “sell” rating to a “hold” rating and boosted their price objective for the stock from $155.00 to $170.00 in a report on Wednesday, November 6th. Finally, Wells Fargo & Company upgraded Clorox from an “underweight” rating to an “equal weight” rating and increased their target price for the company from $155.00 to $157.00 in a research note on Tuesday, January 7th. Four analysts have rated the stock with a sell rating, ten have issued a hold rating and one has issued a buy rating to the company. According to data from MarketBeat.com, Clorox has a consensus rating of “Hold” and a consensus target price of $156.54.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.